To grow is to progress,
To progress is to evolve,
To evolve is to succeed.
API R & D is approved by DSIR, Govt. of India. It is a fully equipped lab set up for synthesis, process and analytical research.
Enaltec’s Formulation Development Center is completely dedicated to development of pharmaceutical product for the worldwide markets considering the patent landscape and development strategy.
API Manufacturing unit is engaged in the manufacturing and supply of API to regulated and semi regulated markets.
2006 : Inception of Enaltec
2007 : API Research & Development Center
2009 : Regulatory Plant Commissioning
2010 : US FDA Registration of Ambernath Plant
Manufacturing block is designed to produce complex, challenging & technologically intensive Active Pharmaceutical Ingredients of high quality that cater to the needs of niche global markets.